Table 2.

Comparison of baseline clinical and demographic variables among AIS patients with and without mismatch

	Mismatch	No mismatch	Significance
Number of patients	35	37
Age, years	64.6±15	66.5±14	0.597a
Male sex	57%	48.6%	0.471b
Median admission NIHSS score	17 (11–20)	11 (6–18)	0.011c
Hypertension	77%	83.4%	0.477b
Admission systolic BP, mm Hg	159±30	152±30	0.345a
Admission diastolic BP, mm Hg	89±14	89±21	0.998a
Diabetes mellitus	31.4%	43%	0.301b
Admission glucose level, mg/dL	136.9±46.5	137±74	0.992a
Hyperlipidemia, mg/dL	57%	67.6%	0.361b
LDL, mg/dL	100±37	107±44	0.493a
HDL, mg/dL	40.3±13	48.8±21	0.052a
Triglyceride, mg/dL	100.9±45	155.2±90	0.003a
Cholesterol, mg/dL	161±41	186±51	0.03a
Coronary artery disease	20%	10.8%	0.279b
Congestive heart failure	20%	19%	0.908b
Atrial fibrillation	42.8%	18.9%	0.028b
Intravenous tPA rate	51.4%	27%	0.034b
Time from stroke onset to MRI, min	295±138	339±161	0.224a
MRI turnaround time, min	90±33	94±55	0.701a
Mortality	14.3%	5.4%	0.254d
Vessel occlusion	91.4%	18.9%	0.000b
Perfusion-diffusion mismatch	85.7%	56.8%	0.007b
Clinical diffusion mismatch	14.3%	43.2%
Endovascular therapy	71.4%	0%	0.000b

BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NIHSS, National Institutes of Health Stroke Scale; tPA, tissue plasminogen activator.

^aStudent t test.

^bχ² test.

^cMann-Whitney U test.

^dFisher exact test.